No phaseRecruiting
Cerebrospinal Fluid Kinetics of Urolithin A (neURO)
Cerebrospinal Fluid Kinetics of Urolithin A in Humans
- Sponsor
- Amazentis SA (Industry)
- Enrolment
- 40 planned
- Conditions
- Healthy Adult
- Interventions
- Mitopure; Placebo
- Ages
- adults
- Registry
- NCT07517913
From the registry
The purpose of this study is to determine the impact of Mitopure® consumption on urolithin A (UA) kinetics in cerebral spinal fluid (CSF).
Primary outcomes
- CSF:plasma ratio